Dr. Bunn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Education & Training
- National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1973 - 1976
- University of California (San Francisco)Residency, Internal Medicine, 1971 - 1973
- Weill Cornell MedicineClass of 1971
Certifications & Licensure
- CO State Medical License 1984 - 2025
- MD State Medical License 1973 - 1986
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FASCO) American Society of Clinical Oncologists, 2007
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer Start of enrollment: 1995 Oct 10
- S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer Start of enrollment: 1999 Oct 01
- Lung Cancer Mutation Consortium Protocol Start of enrollment: 2009 Sep 16
Publications & Presentations
PubMed
- 1298 citationsEpidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung CancerFederico Cappuzzo, Fred R. Hirsch, Elisa Rossi, Stefania Bartolini, Giovanni Luca Ceresoli
Journal of the National Cancer Institute. 2005-05-04 - 207 citationsIASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy.William D. Travis, Sanja Dacic, Ignacio I. Wistuba, Lynette M. Sholl, Prasad S. Adusumilli
Journal of Thoracic Oncology. 2020-05-01 - 192 citationsRecombinant Leukocyte A Interferon: An Active Agent in Advanced Cutaneous T-Cell LymphomasPaul A. Bunn, Kenneth A. Foon, Daniel C. Ihde, Dan L. Longo, Joyce L. Eddy
Annals of Internal Medicine. 1984-10-01
Press Mentions
- Major Project to Address ‘Urgent Need’ for Improved Testing of Cancer TherapiesAugust 21st, 2024
- Verastem Oncology Reports Second Quarter 2021 Financial Results and Highlights Recent Company ProgressAugust 2nd, 2021
- With GlaxoSmithKline in the Rearview Mirror, Abbas Hussain Is Ready to Lead a Biotech of His Own; Doug Treco Scores First CEO Job Since Ra Pharma BuyoutJune 25th, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: